NCT04483349View on ClinicalTrials.gov

Assessment of What Patients and Healthcare Providers Value

CompletedOBSERVATIONAL
Enrollment

397

Participants

Timeline

Start Date

June 11, 2020

Primary Completion Date

August 11, 2022

Study Completion Date

August 11, 2022

Conditions
Gastric AdenocarcinomaPancreatic AdenocarcinomaPancreatic Neuroendocrine Carcinoma
Interventions
OTHER

Survey Administration

Complete survey

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT04483349 - Assessment of What Patients and Healthcare Providers Value | Biotech Hunter | Biotech Hunter